From chronic pain to 12,000 steps a day: Lynnette’s story of renewal

For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her back ...
Monthly Prescribing Reference

Evoke SCS System Approved for Chronic Intractable Pain

Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials. The Food and Drug Administration (FDA) has approved the Evoke ® Spinal ...
Business Wire

Spinal Modulation Axium™ Spinal Cord Stimulator System (SCS) Shows Promise in Managing Chronic Pain in Difficult Pain Conditions

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...
Healio

Q&A: Spinal cord stimulation system offers nonopioid solution to pain management

Please provide your email address to receive an email when new articles are posted on . Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic ...
Monthly Prescribing Reference

FDA Approves Unique SCS System for Chronic Pain

The Food and Drug Administration (FDA) has approved the Senza Omnia Spinal Cord Stimulation (SCS) System (Nevro) for the treatment of chronic intractable pain of the trunk and/or limbs. The Omnia SCS ...
Nasdaq

Abbott's (ABT) Eterna SCS System Receives FDA's Approval

Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
Business Wire

St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a Patient-Centric, Recharge-Free, Upgradeable and MR-conditional Chronic Pain Treatment Option

“The approval of the Proclaim Elite recharge-free SCS system is a needed advancement for both patients and physicians who now have access to a low-maintenance chronic pain treatment that can reduce ...
Morningstar

New Data Show Significant Pain Relief, Reduced Opioid Use, Decreased Patient Time and Cost Burdens with the ProsperaTM SCS System

24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
Nasdaq

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...
Healio

FDA approves spinal cord stimulation system for chronic, nonsurgical back pain

Please provide your email address to receive an email when new articles are posted on . Abbott has announced the FDA expanded the indication of its BurstDR spinal cord stimulation devices for treating ...
Seeking Alpha

Nevro: Potentially Better Than Traditional SCS Treatment For Pain And Undervalued

Nevro is a company dedicated to the design and manufacture of medical devices. I believe that further news about the efficacy of the product, sufficient marketing, and internationalization efforts ...